Related Experiment Video
Updated: Jul 15, 2025

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
7.6K
Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment
1Department of Biomedical Engineering, Lund University, 221 00 Lund, Sweden.
International Journal of Molecular Sciences
|September 28, 2023
Summary
Malignant melanoma is an aggressive skin cancer with increasing incidence. Understanding its complex biology, including tumor microenvironment and cellular plasticity, is key to improving patient treatment and outcomes.
Area of Science:
- Oncology
- Dermatology
- Cancer Biology
Background:
- Malignant melanoma is an aggressive skin cancer with rising global incidence, particularly in young adults.
- Despite advances in immunotherapy and targeted therapy, many patients experience treatment relapse or inadequate response.
- Tumor heterogeneity and complex interactions within the tumor microenvironment contribute to varied disease progression patterns.
Purpose of the Study:
- To review the intricate relationship between melanoma pathogenesis, genetic alterations, and the tumor microenvironment.
- To explore the roles of cellular plasticity and metabolic reprogramming in melanoma development and progression.
- To highlight the need for a deeper understanding of melanomagenesis for personalized patient care.
Main Methods:
- Literature review focusing on key aspects of melanoma biology.
- Analysis of the interplay between tumor genetics, microenvironment, and cellular behavior.
- Synthesis of current knowledge on metabolic reprogramming in melanoma.
Main Results:
- Melanoma's aggressive nature is linked to its heterogeneity and metastatic potential.
- Tumor-host interactions and cellular plasticity drive diverse disease phenotypes.
- Metabolic reprogramming significantly influences melanoma progression.
Conclusions:
- A comprehensive understanding of melanoma's multifaceted features is crucial for advancing treatment strategies.
- Personalized, patient-centered management can improve outcomes and reduce ineffective treatment costs.
- Further research into melanoma biology, including its microenvironment and metabolism, is essential.
Keywords:
cellular plasticitymalignant melanomametabolic reprogrammingmolecular classificationsmutational burdenphenotype switchingtreatment resistancetumor microenvironmentMore Related Videos
Related Concept Videos
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

